Attention Laurel Patients:¬† Effective, Tues May 28th, the new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707……¬† Attention¬† Annapolis Patients: The One Community in Care event will be held on June 8th from 11am-2pm in the Annapolis parking lot.

Trial Protocol ID USOR 21462_GLSI-21-01_FLAMINGO

Trial Description

A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and Postoperative Trastuzumab-based Therapy (FLAMINGO-01)

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jeanine L Werner, M.D.

Disease Types

Sponsor

  • Greenwich Life Sciences

ClinicalTrials.gov NCT ID

  • NCT05232916